NAC-GED-0507 is an innovative potential new medicinal product for the treatment of acne and psoriasis
NAC-GED-0507 gel has achieved clinical proof of concept in patients affected by acne
NAC-GED-0507 cream has shown preliminary efficacy in patients affected by psoriasis
5 completed clinical trials, more than 500 patients treated with active, very favorable safety profile
A large CT in 450 acne patients completed and topline results available showing statistical superior efficacy of 5% Gel over placebo (p < 0.0001) in terms of IGA and lesions count
Additional potential indications are being exploited such as treatment of the rare diseases: Lichen Planopilaris, Localized Scleroderma
New formulations are being developed (e.g. Foam for psoriasis treatment)
Novel mechanism of action, eliciting anti-inflammatory and lipid-modulating properties in sebocytes and keratinocytes
Patent portfolio includes issued patents in the U.S., EP and worldwide to the composition of matter and to the treatment of acne and psoriasis, with an estimated expiry of 2030